William Plovanic
Stock Analyst at Canaccord Genuity
(1.77)
# 3,266
Out of 4,455 analysts
638
Total ratings
41.3%
Success rate
0.1%
Average return
Main Sectors:
Stocks Rated by William Plovanic
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TLSI TriSalus Life Sciences | Maintained: Buy | $7 | $4.73 | +47.99% | 19 | Jun 24, 2026 | |
| AORT Artivion | Reiterated: Buy | $36 | $23.61 | +52.48% | 10 | Jun 16, 2026 | |
| TMDX TransMedics Group | Maintained: Buy | $124 | $68.44 | +81.18% | 54 | Jun 9, 2026 | |
| PLSE Pulse Biosciences | Initiated Coverage: Buy | $32 | $28.45 | +12.48% | 1 | Jun 4, 2026 | |
| PEN Penumbra | Maintained: Hold | $374 | $316.63 | +18.12% | 30 | Jun 2, 2026 | |
| BSX Boston Scientific | Reiterated: Buy | $71 → $70 | $44.23 | +58.26% | 41 | Jun 1, 2026 | |
| IRTC iRhythm Holdings | Maintained: Buy | $180 → $152 | $118.89 | +27.85% | 34 | Jun 1, 2026 | |
| DXCM DexCom | Reiterated: Buy | $100 → $82 | $70.14 | +16.91% | 44 | May 19, 2026 | |
| HTFL HeartFlow | Maintained: Buy | $43 → $37 | $35.65 | +3.79% | 12 | May 15, 2026 | |
| CVRX CVRx, Inc. | Reiterated: Buy | $10 | $5.86 | +70.65% | 37 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 → $25 | $19.98 | +25.13% | 13 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35 | $16.24 | +115.52% | 13 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $435 → $249 | $158.25 | +57.35% | 43 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $23 | $9.30 | +147.31% | 9 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $53 → $55 | $30.18 | +82.24% | 35 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $300 → $400 | $332.71 | +20.22% | 23 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $5 | $1.25 | +300.00% | 11 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $87 → $85 | $90.78 | -6.37% | 38 | Apr 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3 | $1.34 | +123.88% | 30 | Apr 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $71 → $79 | $86.25 | n/a | 20 | Jan 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $24 → $25 | $17.33 | n/a | 3 | Jan 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $17 → $19 | $13.40 | n/a | 10 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 | $44.93 | n/a | 1 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $150 → $131 | $93.10 | n/a | 14 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $3.66 → $7 | $9.78 | n/a | 2 | Dec 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $32 | $30.04 | n/a | 6 | Nov 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $65 | $22.71 | n/a | 1 | Nov 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $48 → $43 | $29.29 | n/a | 17 | Sep 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $86 → $70 | $71.73 | n/a | 17 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $1.50 | n/a | 7 | Feb 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $3.93 | n/a | 11 | Jan 11, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 | $7.20 | n/a | 6 | Nov 5, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $25 → $22 | - | n/a | 7 | Jul 29, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.0002 | n/a | 6 | Feb 2, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $73 → $63 | $83.43 | n/a | 7 | Jun 5, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $17 → $14 | $7.47 | n/a | 4 | Jul 31, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 | $9.78 | n/a | 1 | Sep 9, 2011 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $18.76 | n/a | 1 | Jun 28, 2011 |
TriSalus Life Sciences
Jun 24, 2026
Maintained: Buy
Price Target: $7
Current: $4.73
Upside: +47.99%
Artivion
Jun 16, 2026
Reiterated: Buy
Price Target: $36
Current: $23.61
Upside: +52.48%
TransMedics Group
Jun 9, 2026
Maintained: Buy
Price Target: $124
Current: $68.44
Upside: +81.18%
Pulse Biosciences
Jun 4, 2026
Initiated Coverage: Buy
Price Target: $32
Current: $28.45
Upside: +12.48%
Penumbra
Jun 2, 2026
Maintained: Hold
Price Target: $374
Current: $316.63
Upside: +18.12%
Boston Scientific
Jun 1, 2026
Reiterated: Buy
Price Target: $71 → $70
Current: $44.23
Upside: +58.26%
iRhythm Holdings
Jun 1, 2026
Maintained: Buy
Price Target: $180 → $152
Current: $118.89
Upside: +27.85%
DexCom
May 19, 2026
Reiterated: Buy
Price Target: $100 → $82
Current: $70.14
Upside: +16.91%
HeartFlow
May 15, 2026
Maintained: Buy
Price Target: $43 → $37
Current: $35.65
Upside: +3.79%
CVRx, Inc.
May 12, 2026
Reiterated: Buy
Price Target: $10
Current: $5.86
Upside: +70.65%
May 12, 2026
Reiterated: Buy
Price Target: $28 → $25
Current: $19.98
Upside: +25.13%
May 8, 2026
Maintained: Buy
Price Target: $35
Current: $16.24
Upside: +115.52%
May 7, 2026
Maintained: Buy
Price Target: $435 → $249
Current: $158.25
Upside: +57.35%
May 6, 2026
Reiterated: Buy
Price Target: $25 → $23
Current: $9.30
Upside: +147.31%
May 6, 2026
Maintained: Buy
Price Target: $53 → $55
Current: $30.18
Upside: +82.24%
May 1, 2026
Reiterated: Buy
Price Target: $300 → $400
Current: $332.71
Upside: +20.22%
Apr 30, 2026
Reiterated: Buy
Price Target: $20 → $5
Current: $1.25
Upside: +300.00%
Apr 24, 2026
Maintained: Hold
Price Target: $87 → $85
Current: $90.78
Upside: -6.37%
Apr 6, 2026
Maintained: Buy
Price Target: $3
Current: $1.34
Upside: +123.88%
Jan 22, 2024
Maintained: Buy
Price Target: $71 → $79
Current: $86.25
Upside: n/a
Jan 22, 2024
Maintained: Buy
Price Target: $24 → $25
Current: $17.33
Upside: n/a
Dec 21, 2023
Maintained: Buy
Price Target: $17 → $19
Current: $13.40
Upside: n/a
Dec 21, 2023
Maintained: Buy
Price Target: $15
Current: $44.93
Upside: n/a
Dec 15, 2023
Maintained: Hold
Price Target: $150 → $131
Current: $93.10
Upside: n/a
Dec 7, 2023
Upgraded: Buy
Price Target: $3.66 → $7
Current: $9.78
Upside: n/a
Nov 30, 2023
Maintained: Hold
Price Target: $32
Current: $30.04
Upside: n/a
Nov 7, 2023
Maintained: Buy
Price Target: $65
Current: $22.71
Upside: n/a
Sep 15, 2023
Maintained: Hold
Price Target: $48 → $43
Current: $29.29
Upside: n/a
Aug 28, 2023
Maintained: Hold
Price Target: $86 → $70
Current: $71.73
Upside: n/a
Feb 2, 2016
Maintained: Buy
Price Target: $8
Current: $1.50
Upside: n/a
Jan 11, 2016
Reiterated: Buy
Price Target: $12
Current: $3.93
Upside: n/a
Nov 5, 2015
Maintained: Buy
Price Target: $16
Current: $7.20
Upside: n/a
Jul 29, 2015
Reiterated: Hold
Price Target: $25 → $22
Current: -
Upside: n/a
Feb 2, 2015
Reiterated: Hold
Price Target: n/a
Current: $0.0002
Upside: n/a
Jun 5, 2014
Maintained: Buy
Price Target: $73 → $63
Current: $83.43
Upside: n/a
Jul 31, 2013
Reiterated: Hold
Price Target: $17 → $14
Current: $7.47
Upside: n/a
Sep 9, 2011
Maintained: Buy
Price Target: $45
Current: $9.78
Upside: n/a
Jun 28, 2011
Reiterated: Buy
Price Target: n/a
Current: $18.76
Upside: n/a